ABSTRACT
Heart rate. Heart rate increases at 30 minutes after injection. Sixty minutes later, heart rate returns to the baseline levels. 
DISCUSSION
The present study suggested that intramuscular administration of scopolamine butylbromide had no significant short-term effects on baPWV, MAP and ABI. Heart rate had a tendency of the transient increase at 30 minutesafter injection of scopolamine butylbromide.
PWV assesses arterial stiffness quantitatively. PWV is well correlated with cardiovascular risk factors, such as age, blood pressure and heat rate. [3] This test has benefits for a prospective indicator of cardiovascular mortality in elder subjects [3] The Rotterdam study of PWV indicates that carotid-femoral PWV is associated with the common carotid intima-media thickness and the severity of plaques in the carotid artery and aorta in older subjects [1] Recently, baPWV is measured easily with form PWV/ABI sphygmograph, Colin AT Company. The benefit and reproducibility of baPWV are studied on this sphygmograph among patients with coronary artery disease, and healthy subjects with and without cardiovascular risk factors. [5] ABI is used as a noninvasive screening test of peripheral arterial disease and for the diagnosis of arteriosclerosis obliterans [2] ABI is measured simultaneously using form PWV/ABI sphygmograph. Effects of treadmill walking stress test (slope 12%, 2.4 km/hour, 3 minutes) on ABI using form PWV/ABI sphygmography are studied in 48 patients with arteriosclerosis obliterans and 80 healthy controls. ABI is reduced significantly in the patients whereas that does not differ before and after treadmill test in healthy subjects. The recovery time of ankle blood pressure is also much longer in the patient group in comparison with the control group (personal communication by Masaki). PWV and ABI may be useful for therapeutic evaluation of coronary heart diseases or stroke. Arterial blood pressure, age and sex are well known to play a major role for the determination of PWV. Several environmental factors, including mental or sympathetic stress, may also contribute to PWV. Serial changes of baPWV and ABI after administration of drugs are reported. Sildenafile citrate, a nitric oxide donor, is a therapeutic drug for ejection dysfunction. This drug also acts as vasodilator on blood pressure and heart rate. After oral administration of sildenafile citrate (25 or 50 mg/body), baPWV and blood pressure using form PWV/ABI device are analyzed in eight men with ejection dysfunction. This drug trends to reduce PWV and blood pressure at 30 and 60 minutes after oral administration (personal communication by Shigemura). Recent report shows effects of a nitric oxide synthase inhibitor on PWV [6] When L-NG-monomethyl arginine is intravenously given to eight healthy men, aortic PWV and MAP are increased dose-dependently.
Our results elucidate that heart rate responds on scopolamine butylbromide-stress test. Anticholinergic effects of this drug starts at approximately 5-10 minutes after intramuscular injection. The effects for gastrography withdraw less than 40 minutes although the serological half time is 2 to 6 hours in human. Those pharmacological data are in a similar way to transient increase of heart rate at 30 minutes after administration of scopolamine butylbromide in our subjects. Previous report suggests that augmentation index is inversely correlated with heart rate during right atrial pacing (80-120 beats/min) in twenty healthy subjects. Aortic PWV is not modified by acute changes of heart rate. [7] However, another report shows that PWV depends on heart rate. Aortic PWV is measured at five different pacing frequencies (60-100 beats/min) in 22 older patients with permanent cardiac pacing. PWV is increased during pacing although blood pressure is not varied. Those results points out that heart rate is more important factor for variation of PWV in older patients, rather than blood pressure. [3] PWV need to be carefully interpreted with changes of heart rate in older subjects. In our studies, heart rate temporally responds on scopolamine butylbromide. There are no significant changes of MAP, ABI and PWV between before and after injection of scopolamine butylbromide. Thus, we design to perform baPWV at least the interval time >60 minutes after injection of scopolamine butylbromide. PWV should be measured again in other day if heart rate is markedly increased after administration of this anticholinergic drug, especially in older subjects.
